Health News Releases

  • Today May 19
May 25, 2017 10:55
IPF patients treated with OFEV® (nintedanib) versus placebo were twice as likely to have improved or stable lung function[1]
Boehringer Ingelheim today announced the presentation of new analyses on the use of OFEV® (nintedanib) in treating idiopathic pulmonary fibrosis (IPF) at the 2017 American Thoracic Society (ATS) confe
May 24, 2017 11:50
ATS 2017 Spiriva® Respimat® improves breathing for people with asthma regardless of BMI or allergic status
Boehringer Ingelheim today announced new analyses that provide further evidence that adding tiotropium Respimat® (Spiriva® Respimat®) improved breathing across diverse patient populations who experien
May 23, 2017 15:20
LMD’s V-Sensor Set to Measure Vital Signs in India
Leman Micro Devices (LMD), the developer of regulated consumer healthcare products that is backed by major players within the mobile device industry, has announced that its V-Sensor and app - the only
May 23, 2017 13:25
Octapharma Underlines Strong Commitment to Haemophilia A Patients with the Publication of New Clinical Data on PK-guided Personalized Prophylaxis According to the NuPreviq Approach with Nuwiq®
Octapharma announces positive new clinical data in 66 previously treated patients (PTPs) with severe haemophilia A (HA) undergoing PK-guided personalized prophylaxis with Nuwiq® according to the NuPre
May 22, 2017 17:50
Stuart Raetzman Appointed CEO of Nestlé Skin Health
Nestlé has appointed Stuart Raetzman as CEO of Nestlé Skin Health, effective immediately. “I am very pleased that Stuart will be leading Nestlé Skin Health as CEO. Nestlé’s purpose is to enhance qu
May 22, 2017 14:55
Herbalife Nutrition Inspires Southeast Asia Member Community to be Change Agents for Healthy Active Living in the Region
Herbalife, a global nutrition company, has concluded its annual Asia Pacific Extravaganza 2017, held from May 19 to 21 in Bangkok, Thailand, to a rousing reception. As a training event organized for H
May 17, 2017 11:55
Boehringer Ingelheim strengthens early science portfolio through comprehensive multifaceted partnership with Peking University
Boehringer Ingelheim and Peking University (PKU) today announced an ambitious strategic partnership with the aim of jointly advancing early science innovation across a range of areas of high medical n
May 16, 2017 17:05
Study results demonstrate 74% reduction in surgical site infections with use of PICO™ Single use Negative Pressure Wound Therapy system
Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, proudly supports results of an independent, randomised clinical trial[1] concluding that, in the patients studied, the use of
May 16, 2017 16:45
Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing Facility in China
Today, Boehringer Ingelheim inaugurated its commercial production site for biopharmaceuticals in Zhang Jiang Hi-tech Park of Shanghai (China). The site, with the first-phase investment of more than €7
May 16, 2017 16:00
Herbalife Nutrition Urges Southeast Asia Consumers to Actively Combat Obesity with Balanced Nutrition Habits
Global nutrition company, Herbalife (NYSE:HLF), is urging Southeast Asia consumers to actively combat obesity by adopting balanced nutrition habits in everyday living. Speaking at a lunch symposium of
May 11, 2017 15:50
SERMO Unveils First Global Physician-to-Physician Drug Ratings Tool
SERMO, the largest global social network for physicians with 650,000 members worldwide, today announced the groundbreaking new “Drug Ratings” tool. Drug Ratings is the first and only global peer-to-pe
May 11, 2017 13:45
Takeda Reports FY2016 Full Year Results and Issues FY2017 Guidance
Takeda Pharmaceutical Company Limited (TOKYO:4502): Delivered substantial profit growth versus prior year · Underlying Revenue grew +6.9%, with Takeda's Growth Drivers (GI, Oncology, CNS and Eme
May 09, 2017 13:30
Takeda Announces Publication of ALUNBRIG™ (brigatinib) Pivotal Phase 2 ALTA Clinical Trial Data in Journal of Clinical Oncology
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that data from the pivotal Phase 2 ALTA (ALK in Lung Cancer Trial of AP26113) clinical trial evaluating ALUNBRIG™ (brigatinib) in pati
May 04, 2017 17:10
Athersys Partnering With MedCision on High-Volume ThawSTAR Cell Thawing Systems for Use in Clinical Trials
MedCision, LLC., the world leader in the automation of cell thawing, and Athersys, Inc., a clinical-stage biotechnology company developing proprietary cell therapies, have formed a strategic partnersh
May 01, 2017 14:00
Takeda Announces FDA Accelerated Approval of ALUNBRIG™ (brigatinib)
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG™ (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration (FDA) for the treatment of pa
April 20, 2017 23:05
Replicor discloses achievement of 1 year functional control of HBV and HDV with NAPs and new mechanistic insights in NAP pharmacology
Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic HBV and HDV infection, today disclosed significant new data on NAP activity in HBV and HDV infections at the Euro
April 19, 2017 13:50
Synexus to Advance Capabilities as World’s Leading Site Network
European-headquartered Synexus and U.S.-based Radiant Research today announced a full operational integration to form a single global site network of 185 sites with 1,500 employees. This move will cre
April 12, 2017 17:00
PSMF Invites International Patient Safety Community to Attend its 5th Annual Midyear Planning Meeting on July 13, 2017
The Patient Safety Movement Foundation (PSMF) invites patient safety experts, medical care providers, hospital administrators, patient advocates and policy makers from around the world to discuss chal
April 12, 2017 13:30
Low-Level Light Therapy Accelerates Hair Growth in Chemotherapy Patients
Photobiomodulation therapy, or low-level light therapy (LLLT), has been shown to accelerate hair recovery by 2.6x in patients with chemotherapy-induced alopecia (CIA), according to preliminary finding
April 11, 2017 13:45
Fresenius Medical Care AG & Co. KGaA Published Form 20-F for the Fiscal Year 2016
Fresenius Medical Care AG & Co. KGaA (“the company” or “Fresenius Medical Care”), the world‘s largest provider of dialysis products and services, announced that it has filed the annual report 2016 und
April 11, 2017 11:45
Takeda Enters into Strategic Collaboration with NuBiyota for Microbiome Therapeutics
Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced a strategic collaboration with NuBiyota LLC for the development of Microbial Ecosystem Therapeutic products for gastroenterology (GI)
April 11, 2017 10:15
Ferring Announces Exclusive Agreement with Alrise Biosystems for the Development of an Injectable, Controlled-Release Peptide
Ferring Pharmaceuticals and Alrise Biosystems announced today that the companies have entered into a development agreement with exclusive option rights for Ferring to leverage Alrise’s ImSus® Technolo
April 07, 2017 11:05
Ferring Highlights Progress on Social and Environmental Goals in Corporate Social Responsibility (CSR) Review 2015-2016
Ferring Pharmaceuticals releases its second Corporate Social Responsibility (CSR) review, highlighting progress on social and environmental goals in 2015 and 2016 across four key pillars for focus and
April 06, 2017 12:00
Herbalife Nutrition Study Reveals Alarming Lack of Nutrition, Hydration and Exercise among Adults
Herbalife, a global nutrition company, has released the findings from its Asia Pacific Balanced Nutrition Survey[1], which focuses on shedding light on nutrition and health habits, behaviors and attit
April 06, 2017 10:55
Takeda Completes Enrollment of More Than 20,000 Children and Adolescents in Global Phase 3 Trial of Dengue Vaccine Candidate
Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that it has completed enrollment of 20,100 children and adolescents ages 4 through 16 in its global, pivotal Phase 3 Tetra
25 per page50 per page75 per page100 per page